BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 17079095)

  • 1. Selective inhibition of Alu retrotransposition by APOBEC3G.
    Hulme AE; Bogerd HP; Cullen BR; Moran JV
    Gene; 2007 Apr; 390(1-2):199-205. PubMed ID: 17079095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition.
    Chiu YL; Witkowska HE; Hall SC; Santiago M; Soros VB; Esnault C; Heidmann T; Greene WC
    Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15588-93. PubMed ID: 17030807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of LINE-1 and Alu retrotransposition by exosomes encapsidating APOBEC3G and APOBEC3F.
    Khatua AK; Taylor HE; Hildreth JE; Popik W
    Virology; 2010 Apr; 400(1):68-75. PubMed ID: 20153011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G.
    Holmes RK; Koning FA; Bishop KN; Malim MH
    J Biol Chem; 2007 Jan; 282(4):2587-95. PubMed ID: 17121840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F.
    Tian C; Yu X; Zhang W; Wang T; Xu R; Yu XF
    J Virol; 2006 Mar; 80(6):3112-5. PubMed ID: 16501124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dancin' deaminase.
    Harris RS; Matsuo H
    Nat Struct Mol Biol; 2006 May; 13(5):380-1. PubMed ID: 16738602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual inhibitory effects of APOBEC family proteins on retrotransposition of mammalian endogenous retroviruses.
    Esnault C; Millet J; Schwartz O; Heidmann T
    Nucleic Acids Res; 2006; 34(5):1522-31. PubMed ID: 16537839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation.
    Luo K; Wang T; Liu B; Tian C; Xiao Z; Kappes J; Yu XF
    J Virol; 2007 Jul; 81(13):7238-48. PubMed ID: 17428847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOBEC3G oligomerization is associated with the inhibition of both Alu and LINE-1 retrotransposition.
    Koyama T; Arias JF; Iwabu Y; Yokoyama M; Fujita H; Sato H; Tokunaga K
    PLoS One; 2013; 8(12):e84228. PubMed ID: 24367644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal and C-terminal cytosine deaminase domain of APOBEC3G inhibit hepatitis B virus replication.
    Lei YC; Tian YJ; Ding HH; Wang BJ; Yang Y; Hao YH; Zhao XP; Lu MJ; Gong FL; Yang DL
    World J Gastroenterol; 2006 Dec; 12(46):7488-96. PubMed ID: 17167839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOBEC3G & HTLV-1: inhibition without deamination.
    Strebel K
    Retrovirology; 2005 May; 2():37. PubMed ID: 15921532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human retroviral host restriction factors APOBEC3G and APOBEC3F localize to mRNA processing bodies.
    Wichroski MJ; Robb GB; Rana TM
    PLoS Pathog; 2006 May; 2(5):e41. PubMed ID: 16699599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral potency of APOBEC proteins does not correlate with cytidine deamination.
    Bishop KN; Holmes RK; Malim MH
    J Virol; 2006 Sep; 80(17):8450-8. PubMed ID: 16912295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of antiviral cytidine deaminases does not explain the inhibition of hepatitis B virus replication by interferons.
    Jost S; Turelli P; Mangeat B; Protzer U; Trono D
    J Virol; 2007 Oct; 81(19):10588-96. PubMed ID: 17652382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of APOBEC3G binding to 7SL RNA.
    Bach D; Peddi S; Mangeat B; Lakkaraju A; Strub K; Trono D
    Retrovirology; 2008 Jul; 5():54. PubMed ID: 18597676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOBEC3G targets human T-cell leukemia virus type 1.
    Sasada A; Takaori-Kondo A; Shirakawa K; Kobayashi M; Abudu A; Hishizawa M; Imada K; Tanaka Y; Uchiyama T
    Retrovirology; 2005 May; 2():32. PubMed ID: 15943885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities.
    Langlois MA; Beale RC; Conticello SG; Neuberger MS
    Nucleic Acids Res; 2005; 33(6):1913-23. PubMed ID: 15809227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection.
    Pion M; Granelli-Piperno A; Mangeat B; Stalder R; Correa R; Steinman RM; Piguet V
    J Exp Med; 2006 Dec; 203(13):2887-93. PubMed ID: 17145955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA deaminases AID and APOBEC3G act processively on single-stranded DNA.
    Pham P; Chelico L; Goodman MF
    DNA Repair (Amst); 2007 Jun; 6(6):689-92; author reply 693-4. PubMed ID: 17291835
    [No Abstract]   [Full Text] [Related]  

  • 20. APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo.
    Liddament MT; Brown WL; Schumacher AJ; Harris RS
    Curr Biol; 2004 Aug; 14(15):1385-91. PubMed ID: 15296757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.